US Bancorp’s Yarrow Bioscience YARW Stock Holding History

US Bancorp’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$112K	Buy	+4,992	New	+$170K	﹤0.01%	2392
2024 Q1	–	Sell	-89	Closed	-$10.4K	–	4109
2023 Q4	$10.4K	Hold	89	–	–	﹤0.01%	3307
2023 Q3	$18K	Buy	+89	New	+$19.4K	﹤0.01%	2936

Other funds holding YARW

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

MB, Levis & Associates Center Valley, Pennsylvania $273M AUM 8.08% 1-Year Est. Return

Hurley Capital New York $206M AUM 18.12% 1-Year Est. Return

US Bancorp's YARW Position: Q3 2026 in Review

US Bancorp opened a new position in Yarrow Bioscience (YARW) in Q3 2026: 4,992 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #2392 among its holdings. This is a return to the name: US Bancorp previously reported a position in YARW as recently as Q4 2023.

US Bancorp first reported a position in YARW in Q3 2023 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold YARW as of Q3 2026.

US Bancorp held 4,992 shares of Yarrow Bioscience worth $112K as of Q3 2026.
Yarrow Bioscience was a new US Bancorp position in Q3 2026.
Yarrow Bioscience made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #2392 holding.
US Bancorp first reported a position in Yarrow Bioscience in Q3 2023 and has held it in 3 quarters since.
6 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.